Laura H V G Gil

Title: Laura H V G Gil: Innovator in Dengue Hemorrhagic Fever Detection

Introduction

Laura H V G Gil is a prominent inventor based in Recife, Brazil. She has made significant contributions to the field of medical diagnostics, particularly in the detection of dengue hemorrhagic fever (DHF). Her innovative work has the potential to improve patient outcomes through early diagnosis and intervention.

Latest Patents

Laura holds a patent for a method and biomarkers for the detection of dengue hemorrhagic fever. The present invention provides compositions and methods for detecting, analyzing, and identifying biomolecules used to diagnose patients at risk of DHF. More particularly, the invention includes plasma biomarkers such as the complement factor D to complement factor H (FactorD/FactorH) ratio and levels of one or more of IL2, desmoplakin, and high molecular weight albumin, which are utilized to detect the risk of developing DHF.

Career Highlights

Laura is affiliated with the University of Texas System, where she continues her research and development in medical diagnostics. Her work is crucial in addressing public health challenges associated with dengue fever, a disease that poses significant risks in tropical and subtropical regions.

Collaborations

Some of her notable coworkers include Eduardo Nascimento and Heidi Spratt, who contribute to her research efforts and help advance the understanding of dengue fever diagnostics.

Conclusion

Laura H V G Gil is a dedicated inventor whose work in the detection of dengue hemorrhagic fever exemplifies the importance of innovation in healthcare. Her contributions are paving the way for better diagnostic methods and improved patient care.